
Organigram's $561-Million Bid for Aurora Cannabis Ends a Hostile Takeover Fight
Organigram Global's $561-million agreement to buy Aurora Cannabis ends a hostile bid from Curaleaf, consolidates EU-GMP certified production, and signals a pivot toward medical exports.
















